Permanent Atrial Fibrillation: Clinical Trials

4 trials for Permanent Atrial Fibrillation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Permanent Atrial Fibrillation: new trials by email Literature Review of Permanent Atrial Fibrillation trials Research Report on Permanent Atrial Fibrillation

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)
Bisoprolol, Digoxin - Permanent Atrial Fibrillation
Phase 4CompletedUniversity of Birmingham1612016-12-202021-06-18
Rate Control in Atrial Fibrillation II
Metoprolol, Diltiazem - Atrial Fibrillation, Permanent Atrial Fibrillation
Phase 4CompletedAsker & Baerum Hospital1222016-02-012022-01-05
Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
Rivaroxaban, Fluindione, Warfarin - Permanent Atrial Fibrillation, Venous Thrombosis
Phase 4CompletedUniversity Hospital, Angers512013-05-212019-11-07
Heart Rate Regularization in Patients With Permanent Atrial Fibrillation Post Marketing Study
Vitatron pacemaker C20 SSIR or T20 SSIR models - Permanent Atrial Fibrillation
Phase 4CompletedMedtronic BRC672006-01-012011-09-28

Narrower conditions

Atrial Fibrillation (2)  ·  Arrhythmias, Cardiac (1)  ·  Heart Diseases (1)  ·  Pathologic Processes (1)  ·  Pulmonary Embolism (1)  ·  Venous Thrombosis (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Arrhythmias, Cardiac (1)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Heart Diseases (1)  ·  Lung Diseases (1)  ·  Pathologic Processes (1)  ·  Respiratory Tract Diseases (1)  ·  Thrombosis (1)  ·  Vascular Diseases (1)

Interventions

Bisoprolol (1)  ·  Digoxin (1)  ·  Diltiazem (1)  ·  Metoprolol (1)  ·  Rivaroxaban (1)  ·  Warfarin (1)  ·  fluindione (1)

Sponsors

Asker & Baerum Hospital (1)  ·  Medtronic BRC (1)  ·  University Hospital, Angers (1)  ·  University of Birmingham (1)

Countries

France (1)  ·  Italy (1)  ·  Norway (1)  ·  United Kingdom (1)

Top investigators

Dipak Kotecha, MBChB PhD MRCP (1)  ·  Eraldo Occhetta, MD (1)  ·  Gianfranco Mazzocca, MD (1)  ·  Giorgio Corbucci, PhD (1)  ·  Sara Reinvik Ulimoen, MD PhD (1)

Results publications

PMID 28729311, PMID 33351042, PMID 39009776, PMID 39819610, PMID 40087560, PMID 41462450

NIH funding

2015 (1)